Showing results (111-120 of 198) with videos related to

Sort By:
Pageof 20
Clinical Chemistry|June 27, 2019
Direct Versus Calculated LDL Cholesterol and C-Reactive Protein in Cardiovascular Disease Risk Assessment in the Framingham Offspring StudyHiroaki Ikezaki, Virginia A Fisher, Elise Lim, et al.
Internal Medicine (Tokyo, Japan)|June 11, 2019
Toxocariasis Suspected of Having Infiltrated Directly from the Liver to the Lung through the DiaphragmMasaki Kakimoto, Masayuki Murata, Fujiko Mitsumoto-Kaseida, et al.
Antiviral Research|May 21, 2013
Early phase viral kinetics of chronic hepatitis C patients receiving telaprevir-based triple therapy: a comparison of two real-time PCR assaysEiichi Ogawa, Norihiro Furusyo, Masayuki Murata, et al.
BMJ Open Gastroenterology|August 28, 2018
Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in AsiaBin Wei, Fanpu Ji, Yee Hui Yeo, et al.
Archives of Virology|December 15, 2015
Association of IL28B rs8099917 genotype and female sex with spontaneous clearance of hepatitis C virus infection: a Japanese cross-sectional studyHiroaki Ikezaki, Norihiro Furusyo, Satoshi Hiramine, et al.
BMJ Open Gastroenterology|July 14, 2018
Real-world effectiveness of sofosbuvir plus ribavirin for chronic hepatitis C genotype 2 in Asia: a systematic review and meta-analysisBin Wei, Fanpu Ji, Yee Hui Yeo, et al.
Hepatitis Research and Treatment|September 3, 2013
Interferon- α -Induced Changes to Natural Killer Cells Are Associated with the Treatment Outcomes in Patients with HCV InfectionsShinji Shimoda, Kosuke Sumida, Sho Iwasaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 23, 2011
Pegylated interferon α-2b plus ribavirin for Japanese chronic hepatitis C patients with normal alanine aminotransferaseMosaburo Kainuma, Norihiro Furusyo, Koichi Azuma, et al.
The Journal of Antimicrobial Chemotherapy|October 5, 2013
Therapeutic drug monitoring of telaprevir in chronic hepatitis C patients receiving telaprevir-based triple therapy is useful for predicting virological responseNorihiro Furusyo, Eiichi Ogawa, Masayuki Murata, et al.
Internal Medicine (Tokyo, Japan)|September 17, 2014
Hepatitis B virus-related immune reconstitution inflammatory syndrome in two patients coinfected with human immunodeficiency virus diagnosed with a liver biopsyFujiko Mitsumoto, Masayuki Murata, Yoshifumi Kato, et al.
Pageof 20